{
    "clinical_study": {
        "@rank": "84051", 
        "arm_group": [
            {
                "arm_group_label": "NAC", 
                "arm_group_type": "Active Comparator", 
                "description": "Twice daily dosing for 8 weeks"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Twice daily dosing for 8 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "To conduct a pilot randomized placebo-controlled feasibility trial of N-acetylcysteine (NAC)\n      in onychophagia, preliminarily assessing the tolerability and effects of this\n      pharmacotherapy on young adults who bite their fingernails. It is proposed that NAC will\n      help decrease fingernail biting."
        }, 
        "brief_title": "Use of NAC in Fingernail Biting", 
        "condition": "Onychophagia", 
        "condition_browse": {
            "mesh_term": "Nail Biting"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  1. Age 18-30 2. Fingernail biter for \u22655 years\n\n        Exclusion Criteria:\n\n          -  1. Any unstable major DSM-IV Axis I psychiatric disorder in the past month (e.g.,\n             psychotic disorders, bipolar disorder, major depressive disorder) 2. Current\n             substance dependence in the past month 3. Current unstable major medical disorder or\n             medical condition in the past 6 months (e.g., renal impairment) 4. Current pregnancy\n             or breastfeeding 5. Current seizure disorder or asthma, due to possible elevated risk\n             for adverse effects with NAC in individuals with these conditions 6. Known\n             hypersensitivity to NAC 7. Use of carbamazepine or nitroglycerin (or any other\n             medication deemed to be hazardous if taken with NAC) within 14 days of study\n             participation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "30 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01993849", 
            "org_study_id": "Pro00028506"
        }, 
        "intervention": [
            {
                "arm_group_label": "NAC", 
                "intervention_name": "N-Acetylcysteine (NAC)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Acetylcysteine", 
                "N-monoacetylcystine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Anxiety", 
            "Impulse control", 
            "Depression", 
            "ADHD", 
            "Fingernail Biting", 
            "N-Acetylcysteine", 
            "NAC"
        ], 
        "lastchanged_date": "January 24, 2014", 
        "location": {
            "contact": {
                "email": "Pearcea@musc.edu", 
                "last_name": "Amanda P Roper, MD", 
                "phone": "843-792-2123"
            }, 
            "facility": {
                "address": {
                    "city": "Charleston", 
                    "country": "United States", 
                    "state": "South Carolina", 
                    "zip": "29425"
                }, 
                "name": "Medical University of South Carolina"
            }, 
            "investigator": {
                "last_name": "Amanda P Roper, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Placebo-controlled Trial of N-Acetylcysteine in Onychophagia", 
        "other_outcome": [
            {
                "measure": "Craving for nail biting", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Measurement of nail length", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Feasibility of conducting a trial of NAC in fingernail biters.", 
            "safety_issue": "Yes", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01993849"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical University of South Carolina", 
            "investigator_full_name": "Kevin Gray", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Changes in rate of fingernail biting", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "source": "Medical University of South Carolina", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Kevin Gray", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}